UPDATE: JPMorgan Upgrades Esperion Therapeutics (ESPR) to Neutral Citing 'Achievable Estimates as Outcomes Data Nears'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

Go back to UPDATE: JPMorgan Upgrades Esperion Therapeutics (ESPR) to Neutral Citing 'Achievable Estimates as Outcomes Data Nears'
ESPERION THERAP (NASDAQ: ESPR) Delayed: 3.14 --0 (-0%)
Previous Close $3.14    52 Week High $30.41 
Open $3.13    52 Week Low $9.40 
Day High $3.14    P/E N/A 
Day Low $3.13    EPS $-21.87 
Volume 25,112,903